Bullseye Asset Management LLC Ab Cellera Biologics Inc. Transaction History

Bullseye Asset Management LLC

  • $217 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$12.99 - $17.73 $130,523 - $178,151
-10,048 Reduced 36.13%
17,766 $254,000
Q3 2021

Nov 15, 2021
BUY
$14.85 - $21.34 $7,647 - $10,990
515 Added 1.89%
27,814 $557,000
Q1 2021

May 13, 2021
BUY
$23.29 - $53.2 $232,900 - $532,000
10,000 Added 57.81%
27,299 $927,000
Q4 2020

Feb 12, 2021
BUY
$39.0 - $58.9 $674,661 - $1.02 Million
17,299 New
17,299 $695,000

Others Institutions Holding ABCL

# of Institutions
155
Shares Held
108M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $884M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email